Publications by authors named "Danming He"

Claim this Profile
L
Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer.
Yixiang Zhu, Jian Zhang, Danming He, Hongqing Cai, Yan He, Yucheng Dong

Signal Transduct Target Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions.
Yixiang Zhu, Danming He, Zan Hou, Mei Lan, Ye Zhang

Adv Sci (Weinh)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.
Li Yuan, Sini Li, Yixiang Zhu, Lin Yang, Xue Zhang, Zheng Liu, Yan He, DanMing He

EBioMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.
Jie Zhao, Lu Wang, Anda Zhou, Shidi Wen, Wenfeng Fang, Danming He

Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer.
Danming He, Lu Wang, Jiachen Xu, Jie Zhao, Hua Bai

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis